PDCD1 and intrahepatic cholangiocarcinoma: Further, tumor tissues from ICC patients with HBV infection had 68.0±8.9 PD1+ T cells, significantly more than those from patients with hepatolithiasis (9.2±2.5; p < 0.001) and patients with undetermined risk factors (42.4±7.4; p = 0.027).